Milo Kaptein

Oncode Institute is a Dutch cancer research and innovation organisation dedicated to accelerating breakthroughs in cancer research and translating them into impactful diagnostics and treatments. We bring together 62 leading researchers and their teams from 13 partner institutes to pursue cutting-edge, high-risk, high-gain research. Through an integrated approach that bridges discovery, clinical practice, and market needs, Oncode Institute drives the transformation of innovations into tangible benefits for patients. We foster collaboration and drive valorization to maximize impact - advancing science, improving health outcomes, and contributing to economic value. Founded on the pillars of science, collaboration, and valorization, Oncode Institute is committed to outsmarting cancer and impacting lives. Facts & Figures 62 Oncode Investigators (Groupleaders) 750+ researchers connected 13 Key partnerships & collaborations 12 spin offs Press kit For logo's or photo's please reach out to the communication team. Our goal: helping more patients survive, improving the quality of life for those afflicted, and ultimately curing cancer. The complexity of cancer calls for strategic action and collaboration. Instead of new buildings, we are constructing a network, in which experienced, leading scientists and gifted young researchers at partner institutions strive together toward a greater, common goal, supported by KWF Kankerbestrijding and the Dutch Government. Because only by working together we can outsmart cancer. Official launch on February 5th, 2018 If you have any questions or suggestions, please feel free to contact us at anytime. [email protected]